Pricing and reimbursement

Swiss Market Access Strategy

SFL’s experienced team provides strategic advice and operational support for pricing and reimbursement of both medicinal products and medical devices.  

Medicinal Products

  • Market access strategy (inpatient and outpatient setting)
  • Swiss value dossier development, writing and submission (for List of Specialties and Article 71 a/b KVV applications)
  • Consultations of the Federal Office of Public Health (FOPH/BAG)

Medical Devices  

  • Identification of adequate reimbursement pathways
  • Swiss value dossier development, writing and submission (for Analyses List and Medical Items List applications)
  • Consultations with the FOPH

Global Value Dossier Development

  • Writing sections on clinical and medical information for the core value dossier of both medicinal products and medical devices
  • Country-specific adjustments and submissions via local experts

Joint regulatory/HTA scientific advice

  • Support for joint regulatory/HTA scientific advice meetings
    • Strategic advice
    • Developing briefing book
    • Preparing slides deck
    • Preparation and rehearsal meeting
    • Liaison with competent authorities
    • Accompanying clients to meetings
    • Answering questions
    • Writing meeting minutes

Putting a value on health and innovation – Examples from UK/EU and Switzerland

This article looks at ongoing developments in the European healthcare sector and provides views from different angles, namely regulatory affairs, public affairs, legal and market access.
Pharmaceutical Physician. 2013;24:6-9.